Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.
Barnett AH, Mackin P, Chaudhry I, Farooqi A, Gadsby R, Heald A, Hill J, Millar H, Peveler R, Rees A, Singh V, Taylor D, Vora J, Jones PB.
J Psychopharmacol. 2007 Jun;21(4):357-73. Review. Erratum in: J Psychopharmacol. 2008 Aug;22(6):699. PMID: 17656425 [PubMed - indexed for MEDLINE]Related articles